552 related articles for article (PubMed ID: 33062720)
1. Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
Richard SA; Kampo S; Hechavarria ME; Sackey M; Buunaaim ADB; Kuugbee ED; Anabah TW
J Immunol Res; 2020; 2020():4582612. PubMed ID: 33062720
[TBL] [Abstract][Full Text] [Related]
2. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
[TBL] [Abstract][Full Text] [Related]
3. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
[TBL] [Abstract][Full Text] [Related]
4. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
6. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
7. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Quiros Roldan E; Biasiotto G; Magro P; Zanella I
Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Fatima U; Rizvi SSA; Fatima S; Hassan MI
J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
10. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
Das RR; Behera B; Mishra B; Naik SS
Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
[TBL] [Abstract][Full Text] [Related]
11. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
Chen X; Geiger JD
Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
[TBL] [Abstract][Full Text] [Related]
12. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
Zhou D; Dai SM; Tong Q
J Antimicrob Chemother; 2020 Jul; 75(7):1667-1670. PubMed ID: 32196083
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
[TBL] [Abstract][Full Text] [Related]
17. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Derwand R; Scholz M
Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070
[TBL] [Abstract][Full Text] [Related]
18. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
Zhao M
Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588
[TBL] [Abstract][Full Text] [Related]
19. A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19.
Chowdhury MS; Rathod J; Gernsheimer J
Acad Emerg Med; 2020 Jun; 27(6):493-504. PubMed ID: 32359203
[TBL] [Abstract][Full Text] [Related]
20. New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine.
Gentile D; Fuochi V; Rescifina A; Furneri PM
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
